Nigel C. Borley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nigel C. Borley has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Nicola Mondaini
2 shared publicationsAbigail O’dOnnell
Urology, St George’s Hospital, London, UK
1 shared publicationChristopher J. Anderson
Urology, St George’s Hospital, London, UK
1 shared publicationDebbie Hopster
1 shared publicationGordon H. Muir
Department of Urology, King's College Hospital, London, UK
1 shared publicationJohan Poulsen
Department of Urology, King's College Hospital, London, UK
1 shared publication
Latest Publications
- 30 May 2014
- Published by Springer Nature
- p. 131-136
Erectile Dysfunction
- 30 May 2014
- Published by Springer Nature
- p. 125-129
Penile Curvature
- Open Access
- 5 September 2006
- Published by Wiley in BJU International
- Vol. 98 (4) , 722-724
INADEQUACIES IN FUNDING FOR THE COST OF NEPHRECTOMIES IN A TERTIARY REFERRAL CENTRE IN THE UK
- 5 September 2006
- Published by Wiley in BJU International
- Vol. 98 (4) , 722-724
Open AccessINADEQUACIES IN FUNDING FOR THE COST OF NEPHRECTOMIES IN A TERTIARY REFERRAL CENTRE IN THE UK
- 1 March 2004
- Vol. 76 (1) , 42
Parasitic manifestation of testicular pain.
Genital filariasis is common in endemic areas of the world. However, filariasis cannot be eliminated from the differential diagnosis of scrotal swellings, as international travel is more frequent. We report a case in a patient in London, UK.
- 1 March 2004
- Vol. 76 (1) , 42
Parasitic manifestation of testicular pain.
Genital filariasis is common in endemic areas of the world. However, filariasis cannot be eliminated from the differential diagnosis of scrotal swellings, as international travel is more frequent. We report a case in a patient in London, UK.
- 1 January 2003
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 37 (5) , 382-386
Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high‐risk” prostate cancer compared to MRI or CT
To compare the accuracy of lymph node staging using pelvic MRI or CT to that of laparoscopic pelvic lymph node dissection (LPLND) in prostate cancer patients prior to radical radiotherapy. A total of 55 consecutive patients at high risk of locally advanced disease [prostate-specific antigen (PSA) > 10 ng/ml, Gleason score 7 or worse on biopsy, normal (99m) Tc bone scan] underwent either a pelvic MRI (n = 42) or CT (n = 13) scan and subsequent LPLND. Preoperative staging was compared to the histology of the lymph node specimens obtained. A total of 20/55 (36.4%) patients had pelvic lymph node metastases confirmed by LPLND. MRI identified three patients (27.3%) with pelvic lymph node metastases and missed eight (72.7%) whilst CT identified none of nine patients with pelvic lymph node metastases. The groups with histologically-positive and -negative nodes had similar mean ages (63 vs 65 years; p = 0.52), Gleason scores (6.8 vs 6.5; p = 0.41) and PSA levels (43.1 vs 31.4 ng/ml; p = 0.56). The presence or absence of lymph node metastases has critical implications for the prognosis and treatment of prostate cancer. In this study both MRI and CT missed many cases of lymph node metastases in "high-risk" patients. While a positive scan seems likely to indicate nodal metastases, the low sensitivity in high-risk patients seems unacceptable if treatment decisions are to be based on accurate staging, and LPLND offers an alternative.
- 1 January 2003
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 37 (5) , 382-386
Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high‐risk” prostate cancer compared to MRI or CT
To compare the accuracy of lymph node staging using pelvic MRI or CT to that of laparoscopic pelvic lymph node dissection (LPLND) in prostate cancer patients prior to radical radiotherapy. A total of 55 consecutive patients at high risk of locally advanced disease [prostate-specific antigen (PSA) > 10 ng/ml, Gleason score 7 or worse on biopsy, normal (99m) Tc bone scan] underwent either a pelvic MRI (n = 42) or CT (n = 13) scan and subsequent LPLND. Preoperative staging was compared to the histology of the lymph node specimens obtained. A total of 20/55 (36.4%) patients had pelvic lymph node metastases confirmed by LPLND. MRI identified three patients (27.3%) with pelvic lymph node metastases and missed eight (72.7%) whilst CT identified none of nine patients with pelvic lymph node metastases. The groups with histologically-positive and -negative nodes had similar mean ages (63 vs 65 years; p = 0.52), Gleason scores (6.8 vs 6.5; p = 0.41) and PSA levels (43.1 vs 31.4 ng/ml; p = 0.56). The presence or absence of lymph node metastases has critical implications for the prognosis and treatment of prostate cancer. In this study both MRI and CT missed many cases of lymph node metastases in "high-risk" patients. While a positive scan seems likely to indicate nodal metastases, the low sensitivity in high-risk patients seems unacceptable if treatment decisions are to be based on accurate staging, and LPLND offers an alternative.